- Home
- ACRV vs PETS Comparison
ACRV vs PETS Comparison
Compare ACRV & PETS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ACRV | PETS |
|---|---|---|
| Founded | 2018 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Retail-Drug Stores and Proprietary Stores |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 56.5M | 61.6M |
| IPO Year | 2022 | 2003 |
Fundamental Metrics
Financial Performance| Metric | ACRV | PETS |
|---|---|---|
| Price | $1.53 | $2.74 |
| Analyst Decision | Buy | Sell |
| Analyst Count | 6 | 1 |
| Target Price | ★ $13.00 | $3.20 |
| AVG Volume (30 Days) | ★ 729.1K | 142.3K |
| Earning Date | 04-20-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 13.14 | ★ 18.92 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $273,800,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $805.34 | $2.98 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.05 | $1.57 |
| 52 Week High | $5.75 | $4.43 |
Technical Indicators
Market Signals| Indicator | ACRV | PETS |
|---|---|---|
| Relative Strength Index (RSI) | 41.92 | 36.85 |
| Support Level | $1.51 | $2.44 |
| Resistance Level | $2.47 | $2.93 |
| Average True Range (ATR) | 0.12 | 0.17 |
| MACD | 0.03 | -0.03 |
| Stochastic Oscillator | 17.17 | 19.38 |
Price Performance
Historical ComparisonAbout ACRV Acrivon Therapeutics Inc.
Acrivon Therapeutics Inc is a clinical-stage biopharmaceutical company developing oncology medicines that the Firm matches to patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient responder identification platform. The company's pipeline includes the Phase 2 lead program, ACR-368, referred to as prexasertib, a targeted oncology asset, as well as preclinical stage pipeline programs targeting critical nodes in the DNA Damage Response and cell cycle regulation pathways, including WEE1, a protein kinase, and PKMYT1, a closely related protein serine/threonine kinase.
About PETS PetMed Express Inc.
PetMed Express Inc along with its subsidiaries is a nationwide pet pharmacy. The company markets prescription and non-prescription pet medications, health products, and supplies for dogs and cats, direct to the consumer. The company generates its revenue by selling pet medications and pet supplies mainly to retail consumers.